Real-world Study on the Management of Hematological Toxicities Associated With Targeted Therapies for Breast Cancer

This study will respect the medication choices of researchers in the study, without specifying which medication to choose for treatment, dosage, mode of administration (including single drug, combination therapy, or sequential therapy), and duration of administration.